Table of Content

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions

2. Key Insights

3. Global Ovarian Cancer Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges

4. Global Ovarian Cancer Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War

5. Global Ovarian Cancer Market by Type
5.1. Introduction
5.2. Epithelial Ovarian Cancer
5.3. Germ Cell Ovarian Cancer
5.4. Stromal Cell Ovarian Cancer
5.5. Primary Peritoneal Cancer

6. Global Ovarian Cancer Market by Treatment Type
6.1. Introduction
6.2. Immunotherapy
6.3. Chemotherapy
6.4. Targeted Therapy
6.5. Surgery
6.6. Others

7. Global Ovarian Cancer Market by Drugs
7.1. Introduction
7.2. Mitotic Inhibitors
7.3. Antirheumatics
7.4. Antipsoriatics
7.5. VEGF/VEGFR Inhibitors
7.6. PARP Inhibitors
7.7. Antineoplastics
7.8. Others

8. Global Ovarian Cancer Market by End User
8.1. Introduction
8.2. Hospitals
8.3. Homecare
8.4. Speciality Centre
8.5. Others

9. Global Ovarian Cancer Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa

10. SWOT Analysis

11. Porter’s Five Forces

12. Market Value Chain Analysis

13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. AbbVie
13.2.2. Aetera Zenteris Inc.
13.2.3. AstraZeneca
13.2.4. Boehringer Ingelheim GmbH
13.2.5. Bristol-Myers Squibb
13.2.6. Clovis Oncology
13.2.7. Eli Lilly and Company
13.2.8. Genentech Inc.
13.2.9. GlaxoSmithKline plc
13.2.10. ImmunoGen
13.2.11. Janssen Pharmaceuticals, Inc.
13.2.12. Johnson & Johnson
13.2.13. Novogen, Inc.
13.2.14. Oasmia Pharmaceuticals
13.2.15. Pfizer
13.2.16. Roche Ltd.
13.2.17. Tesaro Inc.


List of Figures

Figure 1: Global Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 2: Global Ovarian Cancer Market by Type, 2023
Figure 3: Global Ovarian Cancer Market by Treatment Type, 2023
Figure 4: Global Ovarian Cancer Market by Drugs, 2023
Figure 5: Global Ovarian Cancer Market by End User, 2023
Figure 6: Global Ovarian Cancer Market by Region, 2023
Figure 7: Global Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 8: Global Ovarian Cancer Market by Type (in %), 2023 & 2033
Figure 9: Global Epithelial Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 10: Global Epithelial Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 11: Global Germ Cell Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 12: Global Germ Cell Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 13: Global Stromal Cell Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 14: Global Stromal Cell Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 15: Global Primary Peritoneal Cancer Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 16: Global Primary Peritoneal Cancer Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 17: Global Ovarian Cancer Market by Treatment Type (in %), 2023 & 2033
Figure 18: Global Immunotherapy Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 19: Global Immunotherapy Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 20: Global Chemotherapy Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 21: Global Chemotherapy Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 22: Global Targeted Therapy Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 23: Global Targeted Therapy Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 24: Global Surgery Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 25: Global Surgery Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 26: Global Other Treatment Types Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 27: Global Other Treatment Types Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 28: Global Ovarian Cancer Market by Drugs (in %), 2023 & 2033
Figure 29: Global Mitotic Inhibitors Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 30: Global Mitotic Inhibitors Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 31: Global Antirheumatics Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 32: Global Antirheumatics Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 33: Global Antipsoriatics Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 34: Global Antipsoriatics Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 35: Global VEGF/VEGFR Inhibitors Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 36: Global VEGF/VEGFR Inhibitors Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 37: Global PARP Inhibitors Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 38: Global PARP Inhibitors Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 39: Global Antineoplastics Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 40: Global Antineoplastics Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 41: Global Other Drugs Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 42: Global Other Drugs Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 43: Global Ovarian Cancer Market by End User (in %), 2023 & 2033
Figure 44: Global Hospitals Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 45: Global Hospitals Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 46: Global Homecare Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 47: Global Homecare Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 48: Global Speciality Centre Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 49: Global Speciality Centre Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 50: Global Other End Users Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 51: Global Other End Users Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 52: Global Ovarian Cancer Market by Region (in %), 2023 & 2033
Figure 53: Europe Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 54: Europe Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 55: Europe Ovarian Cancer Market by Country (in %), 2023 & 2033
Figure 56: Germany Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 57: United Kingdom Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 58: France Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 59: Italy Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 60: Spain Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 61: Russia Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 62: Netherlands Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 63: North America Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 64: North America Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 65: North America Ovarian Cancer Market by Country (in %), 2023 & 2033
Figure 66: United States Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 67: Canada Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 68: Asia Pacific Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 69: Asia Pacific Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 70: Asia Pacific Ovarian Cancer Market by Country (in %), 2023 & 2033
Figure 71: China Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 72: Japan Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 73: India Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 74: South Korea Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 75: Australia Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 76: Indonesia Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 77: Latin America Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 78: Latin America Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 79: Latin America Ovarian Cancer Market by Country (in %), 2023 & 2033
Figure 80: Mexico Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 81: Brazil Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 82: Argentina Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 83: Middle East & Africa Ovarian Cancer Market (in US$ Million), 2019-2023
Figure 84: Middle East & Africa Ovarian Cancer Market (in US$ Million), 2024-2033
Figure 85: Middle East & Africa Ovarian Cancer Market by Country (in %), 2023 & 2033
Figure 86: Saudi Arabia Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 87: Turkey Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 88: Iran Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 89: UAE Ovarian Cancer Market (in US$ Million), 2019-2033
Figure 90: Market Value Chain

List of Tables

Table 1: Global Ovarian Cancer Market Portraiture
Table 2: Global Ovarian Cancer Market by Type (in US$ Million), 2023 & 2033
Table 3: Global Ovarian Cancer Market by Treatment Type (in US$ Million), 2023 & 2033
Table 4: Global Ovarian Cancer Market by Drugs (in US$ Million), 2023 & 2033
Table 5: Global Ovarian Cancer Market by End User (in US$ Million), 2023 & 2033
Table 6: Global Ovarian Cancer Market by Region (in US$ Million), 2023 & 2033
Table 7: Europe Ovarian Cancer Market by Country (in US$ Million), 2023 & 2033
Table 8: North America Ovarian Cancer Market by Country (in US$ Million), 2023 & 2033
Table 9: Asia Pacific Ovarian Cancer Market by Country (in US$ Million), 2023 & 2033
Table 10: Latin America Ovarian Cancer Market by Country (in US$ Million), 2023 & 2033
Table 11: Middle East & Africa Ovarian Cancer Market by Country (in US$ Million), 2023 & 2033
Table 12: List of Key Players